MaxCyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	46.51	11.07	47.78	18.76	15.21
Short-Term Investments	121.78	216.28	207.26	16.01	1.5
Cash & Cash Equivalents	168.29	227.34	255.04	34.76	16.71
Cash Growth	-25.98%	-10.86%	633.67%	108.05%	-
Receivables	5.78	13.09	6.88	5.17	3.24
Inventory	12.23	8.58	5.2	4.32	3.7
Other Current Assets	3.9	3.26	3.31	1	0.8
Total Current Assets	190.19	252.27	270.43	45.25	24.45
Property, Plant & Equipment	34.75	33.58	13.37	6.49	5.53
Long-Term Investments	42.94	0	0	0	0
Other Long-Term Assets	0.39	0.81	0.32	0.03	0
Total Long-Term Assets	78.08	34.39	13.69	6.53	5.53
Total Assets	268.27	286.65	284.12	51.78	29.99
Accounts Payable	0.74	0.29	1.82	0.89	2.09
Deferred Revenue	5.07	6.71	6.75	4.84	3.19
Current Debt	0.77	0.16	0.53	0.57	0.51
Other Current Liabilities	11.27	8.27	6.52	5.31	3.55
Total Current Liabilities	17.86	15.43	15.62	11.61	9.34
Long-Term Debt	17.97	15.94	5.15	6.15	6.7
Other Long-Term Liabilities	0.28	1.32	0.45	0.79	0.34
Total Long-Term Liabilities	18.25	17.26	5.61	6.94	7.04
Total Liabilities	36.11	32.69	21.22	18.55	16.38
Total Debt	18.74	16.1	5.68	6.72	7.21
Debt Growth	16.45%	183.26%	-15.50%	-6.75%	-
Retained Earnings	-175.8	-137.88	-114.3	-95.22	-83.41
Shareholders' Equity	232.17	253.97	262.9	33.23	13.6
Net Cash / Debt	149.55	211.25	249.36	28.04	9.5
Net Cash / Debt Growth	-29.21%	-15.29%	789.35%	195.23%	-
Net Cash Per Share	1.45	2.08	2.75	0.40	0.17
Working Capital	172.34	236.84	254.82	33.64	15.11
Book Value Per Share	2.25	2.50	2.90	0.48	0.24

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).